A group of techniques that look at the genetic material of embryos created through IVF. These include:
Fertility physician, clinical geneticist and bioethicist Dr Shizuko Takahashi questions why PGT-A is being used to limit – rather than inform – patient choices...
Dr Kate Sheridan Clay, second prize winner in this year's Marcus Pembrey BioNews Writing Competition, explores how PGT-P promises parents greater control over their future children's health and traits. What happens when the embryo they choose fails to fulfil their expectations?...
Belgian fertility pioneer Professor André Van Steirtegheim's book looks back over an incredible career, but lacks personal insights, writes embryologist Emily St John Jones...
A non-invasive form of PGT-A did not improve pregnancy rates in a clinical trial, but did reduce early miscarriages...
People's opinions on using preimplantation genetic testing for non-medical traits do not always reflect the decisions they make about selecting embryos when presented with the results...
PGT-A is widely used to assess the chromosome status of IVF embryos, but how accurately can a biopsy of just a handful of cells predict an embryo's genetic makeup? Dr Desislava Staneva explains why interpreting PGT-A results is more complex than it may first appear...
A review of the podcast Your Best Baby examines the growing commercialisation of PGT-P and the ethical questions raised by selecting embryos based on predicted traits and disease risks...
Dr Alexis Heng Boon Chin advises against using medical savings intended for old age to fund more fertility treatments...
Most common IVF add-ons lack strong evidence of proven benefits for patients, an extensive meta-analysis of trusted studies has shown...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
